• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Seattle Genetics

Seattle Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. ESSA Pharma Inc. Announces Appointment of New Director

    ESSA Pharma Inc. Announces Appointment of New Director

  2. Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Pipeline Review 2015 - 9 Companies & 12 Drug Profiles

    Research and Markets: Anaplastic Large Cell Lymphoma (ALCL) Pipeline Review 2015 - 9 Companies & 12 Drug Profiles

  3. Our Outlook for Health-Care Stocks

    Health-care stocks are on a tear as demand slowly returns.

  4. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  5. Our Outlook for Health-Care Stocks

    While we remain bullish on the sector, health-care growth depends on the economy.

  6. Our Outlook for Health-Care Stocks

    With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.